Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Communications Biology|November 19, 2023
C-X-C domain ligand 14-mediated stromal cell-macrophage interaction as a therapeutic target for hand dermal fibrosisAtsushi Goto, Shingo Komura, Koki Kato, et al.
Microsurgery|October 5, 2020
Reverse radiodorsal artery-pedicled thumb metacarpal vascularized bone graft for osteochondral fracture of the thumb interphalangeal joint with a bone defect: A case reportHitoshi Hirose, Shingo Komura, Akihiro Hirakawa, et al.
Scientific Reports|March 6, 2020
Induced pluripotent stem cell-derived tenocyte-like cells promote the regeneration of injured tendons in miceShingo Komura, Takashi Satake, Atsushi Goto, et al.
Cell Death Discovery|May 22, 2026
S100A4-TLR4-TGF-β axis as a therapeutic target for Dupuytren's contracture in diabetic patientsKoki Kato, Shingo Komura, Yuta Yanagihara, et al.
Stem Cell Reports|March 22, 2016
An EWS-FLI1-Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma DevelopmentShingo Komura, Katsunori Semi, Fumiaki Itakura, et al.
Stem Cell Reports|November 6, 2018
An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans ProgressivaKyosuke Hino, Chengzhu Zhao, Kazuhiko Horigome, et al.
Journal of Bone and Mineral Metabolism|August 10, 2022
Deletion of Tfam in Prx1-Cre expressing limb mesenchyme results in spontaneous bone fracturesHiroki Yoshioka, Shingo Komura, Norishige Kuramitsu, et al.
Scientific Reports|July 16, 2022
Reduced dynamic loads due to hip dislocation induce acetabular cartilage degeneration by IL-6 and MMP3 via the STAT3/periostin/NF-κB axisYutaka Nakamura, Mitsuru Saitou, Shingo Komura, et al.
The Journal of Clinical Investigation|August 1, 2017
Activin-A enhances mTOR signaling to promote aberrant chondrogenesis in fibrodysplasia ossificans progressivaKyosuke Hino, Kazuhiko Horigome, Megumi Nishio, et al.
European Journal of Pharmacology|February 8, 2025
Sodium-glucose cotransporter 2 inhibitor empagliflozin enhances autophagy and reverses remodeling in hearts with large, old myocardial infarctionsSusumu Endo, Hiromitsu Kanamori, Akihiro Yoshida, et al.
Pageof 6